Skip to content

Advertisement

COPD and occupational lung disease

Section edited by Craig Hersh

This section concerns all aspects of COPD, occupational lung disease, and smoking-related disorders including, but not limited to: prevention, diagnosis and management, as well as related molecular genetics, and pathophysiology.

Page 1 of 10
  1. Content type: Research article

    Recently awareness of the importance of Aspergillus colonization in the airway of patients with chronic obstructive pulmonary disease (COPD) was rising. The aim of this study was to investigate the clinical fe...

    Authors: Xunliang Tong, Anqi Cheng, Hongtao Xu, Jin Jin, Yimeng Yang, Sainan Zhu and Yanming Li

    Citation: BMC Pulmonary Medicine 2018 18:55

    Published on:

  2. Content type: Research article

    Interferon lambdas (IFNLs) have important anti-viral/bacterial and immunomodulatory functions in the respiratory tract. How do IFNLs impact COPD and its exacerbations?

    Authors: Adrian Egli, Jyotshna Mandal, Desiree M. Schumann, Michael Roth, Brad Thomas, D. Lorne Tyrrell, Francesco Blasi, Kostantinos Kostikas, Wim Boersma, Branislava Milenkovic, Alicia Lacoma, Katharina Rentsch, Gernot G. U. Rohde, Renaud Louis, Joachim G. Aerts, Tobias Welte…

    Citation: BMC Pulmonary Medicine 2018 18:51

    Published on:

  3. Content type: Research article

    Club cell protein-16 (CC16) expression has been associated with smoking-related lung function decline. The study hypothesis was that CC16 expression in both serum and bronchial epithelium is associated with lu...

    Authors: David Chi-Leung Lam, Hoi-Hin Kwok, Wai-Cho Yu, Fanny Wai-San Ko, Cheuk-Yin Tam, Arthur Chun-Wing Lau, Daniel Yee-Tak Fong and Mary Sau-Man Ip

    Citation: BMC Pulmonary Medicine 2018 18:47

    Published on:

  4. Content type: Research article

    An adequate threshold for the Clinical Chronic Obstructive Pulmonary Disease (COPD) Questionnaire (CCQ) defining more symptomatic COPD patients has not been determined. We aimed to determine the efficacy of th...

    Authors: Yong Suk Jo, Sangshin Park, Deog Kyeom Kim, Chul-Gyu Yoo and Chang-Hoon Lee

    Citation: BMC Pulmonary Medicine 2018 18:38

    Published on:

  5. Content type: Research article

    In the Commonwealth of Independent States (CIS) countries the epidemiology of chronic obstructive pulmonary disease (COPD) is poorly characterized. The objective of this analysis is to present the prevalence, ...

    Authors: Damilya Nugmanova, Yuriy Feshchenko, Liudmyla Iashyna, Olga Gyrina, Kateryna Malynovska, Eljan Mammadbayov, Irada Akhundova, Nadezhda Nurkina, Luqman Tariq, Janina Makarova and Averyan Vasylyev

    Citation: BMC Pulmonary Medicine 2018 18:26

    Published on:

  6. Content type: Research article

    Pneumoconiosis may play an important role in the development of chronic obstructive pulmonary disease (COPD), and the complication of COPD may impose a heavy burden of illness.

    Authors: Yating Peng, Xin Li, Shan Cai, Yan Chen, Weirong Dai, Wenfeng Liu, Zijing Zhou, Jiaxi Duan and Ping Chen

    Citation: BMC Pulmonary Medicine 2018 18:22

    Published on:

  7. Content type: Research article

    Hospitalization for a severe exacerbation of COPD (eCOPD) is an important event in the natural history of COPD. Identifying factors related to mortality 1 year after hospitalization could help determine interv...

    Authors: Cristóbal Esteban, Ady Castro-Acosta, Carlos Jose Alvarez-Martínez, Alberto Capelastegui, José Luis López-Campos and Francisco Pozo-Rodriguez

    Citation: BMC Pulmonary Medicine 2018 18:18

    Published on:

  8. Content type: Research article

    Nasal Highflow (NHF) delivers a humidified and heated airflow via nasal prongs. Current data provide evidence for efficacy of NHF in patients with hypoxemic respiratory failure. Preliminary data suggest that N...

    Authors: Jens Bräunlich, Friederike Mauersberger and Hubert Wirtz

    Citation: BMC Pulmonary Medicine 2018 18:14

    Published on:

  9. Content type: Research article

    Chronic obstructive pulmonary disease is a global problem and available data from sub-Saharan Africa is very limited.

    Authors: Thomas Zoller, Elirehema H. Mfinanga, Tresphory B. Zumba, Peter J. Asilia, Edwin M. Mutabazi, David Wimmersberger, Florian Kurth, Francis Mhimbira, Frederick Haraka and Klaus Reither

    Citation: BMC Pulmonary Medicine 2018 18:11

    Published on:

  10. Content type: Research article

    Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with variable clinical manifestations, structural changes, and treatment responses. In a cohort study, we performed a baseline cluster an...

    Authors: Suhyun Kim, Myoung-Nam Lim, Yoonki Hong, Seon-Sook Han, Seung-Joon Lee and Woo Jin Kim

    Citation: BMC Pulmonary Medicine 2017 17:209

    Published on:

  11. Content type: Research article

    Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is the most common reason for the hospitalization and death of pulmonary patients. The use of antibiotics as adjuvant therapy for AECOPD, ho...

    Authors: Hai-Lin Zhang, Min Tan, Ai-Min Qiu, Zhang Tao and Chang-Hui Wang

    Citation: BMC Pulmonary Medicine 2017 17:196

    Published on:

  12. Content type: Research article

    Recent studies have shown that both adenosine monophosphate activated protein kinase (AMPK) and the mammalian target of rapamycin (mTOR) are energy sensors and are related to autophagy. Our recent reports have...

    Authors: Di Gui, Zhimin Cui, Lin Zhang, Chang Yu, Dan Yao, Min Xu, Mayun Chen, Peiliang Wu, Guoping Li, Liangxing Wang and Xiaoying Huang

    Citation: BMC Pulmonary Medicine 2017 17:191

    Published on:

  13. Content type: Research article

    Multiple breath washout (MBW) became a valuable research tool assessing ventilation heterogeneity. However, routine clinical application still faces several challenges. Deriving MBW parameters from three techn...

    Authors: Frederik Trinkmann, Johannes Götzmann, Daniel Saur, Michele Schroeter, Katharina Roth, Ksenija Stach, Martin Borggrefe, Joachim Saur, Ibrahim Akin and Julia D. Michels

    Citation: BMC Pulmonary Medicine 2017 17:185

    Published on:

  14. Content type: Research article

    Systemic morphine has evidence to support its use for reducing breathlessness in patients with severe chronic obstructive pulmonary disease (COPD). The effectiveness of the nebulized route, however, has not ye...

    Authors: Piotr Janowiak, Małgorzata Krajnik, Zygmunt Podolec, Tomasz Bandurski, Iwona Damps-Konstańska, Piotr Sobański, David C. Currow and Ewa Jassem

    Citation: BMC Pulmonary Medicine 2017 17:186

    Published on:

  15. Content type: Research article

    Change in forced expiratory volume in one second (FEV1) is important for defining severity of chronic obstructive pulmonary disease (COPD). Serological neoepitope markers of collagen turnover may predict rate of ...

    Authors: Diana J. Leeming, Inger Byrjalsen, Jannie M. B. Sand, Asger R. Bihlet, Peter Lange, Ruth Thal-Singer, Bruce E. Miller, Morten A. Karsdal and Jørgen Vestbo

    Citation: BMC Pulmonary Medicine 2017 17:164

    Published on:

  16. Content type: Research article

    Recently, it was shown that chronic tobacco smoking evokes specific cellular and molecular changes in white blood cells by an excess of G protein-coupled receptor 15 (GPR15)-expressing T cells as well as a hyp...

    Authors: Mario Bauer, Beate Fink, Hans-Jürgen Seyfarth, Hubert Wirtz and Armin Frille

    Citation: BMC Pulmonary Medicine 2017 17:159

    Published on:

  17. Content type: Research article

    Combined effects of leaks, mechanical property of respiratory system and upper airway (UA) patency on patient-ventilator synchrony (PVA) and the level of clinically “tolerable” leaks are not well established i...

    Authors: Kaixian Zhu, Claudio Rabec, Jésus Gonzalez-Bermejo, Sébastien Hardy, Sami Aouf, Pierre Escourrou and Gabriel Roisman

    Citation: BMC Pulmonary Medicine 2017 17:145

    Published on:

  18. Content type: Research article

    Nasal high-flow oxygen therapy (HFOT) is a novel treatment option for patients suffering from acute or chronic respiratory failure. Aim of our study was to compare safety and efficacy of HFOT with those of con...

    Authors: Helene Vogelsinger, Michael Halank, Silke Braun, Heinrike Wilkens, Thomas Geiser, Sebastian Ott, Armin Stucki and Christian M. Kaehler

    Citation: BMC Pulmonary Medicine 2017 17:143

    Published on:

  19. Content type: Research article

    Asbestosis and silicosis are progressive pneumoconioses characterized by interstitial fibrosis following exposure to asbestos or silica dust. We evaluated the potential diagnostic biomarkers for these diseases.

    Authors: Changjiang Xue, Na Wu, Xue Li, Meihua Qiu, Xuqin Du and Qiao Ye

    Citation: BMC Pulmonary Medicine 2017 17:144

    Published on:

  20. Content type: Study protocol

    Rehabilitation of patients with chronic obstructive pulmonary disease (COPD) is a key treatment in COPD. However, despite the existing evidence and a strong recommendation from lung associations worldwide, 50%...

    Authors: Henrik Hansen, Theresa Bieler, Nina Beyer, Nina Godtfredsen, Thomas Kallemose and Anne Frølich

    Citation: BMC Pulmonary Medicine 2017 17:140

    Published on:

Page 1 of 10

2016 Journal Metrics

Advertisement